It is indicated for the treatment of pulmonary tuberculosis and for the treatment of asymptomatic carriers of N. meningitidis to eliminate meningococci from the nasopharynx.
Contra-indications:
A history of previous hypersensitivity reaction to any of the rifamycins.
Adverse Effects:
This drug may cause upset stomach, heartburn, nausea, menstrual changes, headache, drowsiness, or dizziness.
Drug Interactions:
This drug should not be used with the following medications because very serious interactions may occur: live bacterial vaccines (e.g., oral typhoid), certain non-nucleoside reverse transcriptase inhibitors (nevirapine, delavirdine, etravirine), voriconazole, HIV protease inhibitors (e.g., saquinavir, ritonavir, indinavir).
Precautions & Warning:
This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using this medication, tell your doctor or pharmacist your medical history, especially of: diabetes, liver problems (e.g., hepatitis), HIV infection, history of alcohol use/abuse. This drug may make you dizzy or drowsy. Do not drive, use machinery, or do any activity that requires alertness until you are sure you can perform such activities safely.
Use in Pregnancy and Nursing Mothers:
Although rifampin has been reported to cross the placental barrier and appear in cord blood, the effect of rifampin, alone or in combination with other antituberculous drugs, on the human fetus is not known. An increase in congenital malformations, primarily spina bifida and cleft palate, has been reported in the offspring of rodents given oral doses of 150-250 mg/kg/day of rifampin during pregnancy. The possible teratogenic potential in women capable of bearing children should be carefully weighed against the benefits of therapy.
Treatment/antidote in The Event of Overdose:
Nausea, vomiting, and increasing lethargy will probably occur within a short time after ingestion; actual unconsciousness may occur with severe hepatic involvement. Brownish-red or orange discoloration of the skin, urine, sweat, saliva, tears and feces is proportional to amount ingested.
Storage instructions:
Store below 25ºC. Protect from moisture. Keep out of reach of children.
 Indications:
It is indicated for the treatment of pulmonary tuberculosis and for the treatment of asymptomatic carriers of N. meningitidis to eliminate meningococci from the nasopharynx.
Contra-indications:
A history of previous hypersensitivity reaction to any of the rifamycins.
Adverse Effects:
This drug may cause upset stomach, heartburn, nausea, menstrual changes, headache, drowsiness, or dizziness.
Drug Interactions:
This drug should not be used with the following medications because very serious interactions may occur: live bacterial vaccines (e.g., oral typhoid), certain non-nucleoside reverse transcriptase inhibitors (nevirapine, delavirdine, etravirine), voriconazole, HIV protease inhibitors (e.g., saquinavir, ritonavir, indinavir).
Precautions & Warning:
This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using this medication, tell your doctor or pharmacist your medical history, especially of: diabetes, liver problems (e.g., hepatitis), HIV infection, history of alcohol use/abuse. This drug may make you dizzy or drowsy. Do not drive, use machinery, or do any activity that requires alertness until you are sure you can perform such activities safely.
Use in Pregnancy and Nursing Mothers:
Although rifampin has been reported to cross the placental barrier and appear in cord blood, the effect of rifampin, alone or in combination with other antituberculous drugs, on the human fetus is not known. An increase in congenital malformations, primarily spina bifida and cleft palate, has been reported in the offspring of rodents given oral doses of 150-250 mg/kg/day of rifampin during pregnancy. The possible teratogenic potential in women capable of bearing children should be carefully weighed against the benefits of therapy.
Treatment/antidote in The Event of Overdose:
Nausea, vomiting, and increasing lethargy will probably occur within a short time after ingestion; actual unconsciousness may occur with severe hepatic involvement. Brownish-red or orange discoloration of the skin, urine, sweat, saliva, tears and feces is proportional to amount ingested.
Storage instructions:
Store below 25ºC. Protect from moisture. Keep out of reach of children.
Â
(1) According to the working mode, it can be divided into wet urine analyzer and dry urine analyzer. The dry urine analyzer is mainly used to automatically evaluate the results of the dry test paper method. Because of its simple structure and convenient use, it is widely used in clinical practice.
(2) According to the classification of test items, it can be divided into 8 items, 9 items, 10 items, 11 items, 12 items, 13 items and 14 items. The testing items included urinary protein, urinary glucose, urinary pH, urinary ketone body, urinary bile erythroplasm, urinary bile gen, urinary occult blood, nitrite, urinary white blood cell, urinary specific gravity, vitamin C and turbidity.
(3) According to the degree of automation, it can be divided into semi-automatic urine analyzer and automatic urine analyzer.
YD-200 urine analyzer is a kind of adopt latest optoelectronic technology and microprocessor technology for Clinical urine test; it is user-friendly, and accurate. URS-11A urine strip is dedicated for YD-200. YD-200 can provide 11 items results of quantitative or semi-quantitative for Urobilinogen, Bilirubin, Ketone, Blood, Protein, Micro-albumin ,Nitrite, Leucocytes, Glucose, Specific gravity, pH, Vitamin C.
Urine Analyzer,Urine Test Device,Urine Chemical Analysis
Changchun ZYF science and technology CO.,LTD , https://www.zyf-medical.com